CIK 0001818794
- Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364883909
- Phone
- +1 781-786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $40,000
- in 1 filing
- Open-market sales, last 90 days
- $421,679
- in 7 filings, $422K under 10b5-1 plans
Net −$381,679. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-21 | HURWITZ EDWARD Director | Conversion | +4,614,943 | 4,614,943 | ||
| 2020-09-21 | HURWITZ EDWARD Director | Conversion | +245,279 | 245,279 | ||
| 2020-09-21 | HURWITZ EDWARD Director | Conversion | +91,081 | 91,081 | ||
| 2020-09-21 | HURWITZ EDWARD Director | Conversion · Series A Preferred Stock | −13,980,992 | 0 | ||
| 2020-09-21 | HURWITZ EDWARD Director | Conversion · Series A Preferred Stock | −743,076 | 0 | ||
| 2020-09-21 | HURWITZ EDWARD Director | Conversion · Series A Preferred Stock | −275,932 | 0 | ||
| 2020-09-21 | HURWITZ EDWARD Director | Conversion · Series B Preferred Stock | −1,326,313 | 0 | ||
| 2020-09-21 | HURWITZ EDWARD Director | Conversion · Series B Preferred Stock | −70,492 | 0 | ||
| 2020-09-21 | HURWITZ EDWARD Director | Conversion · Series B Preferred Stock | −26,176 | 0 | ||
| 2020-09-17 | HIGH SUSANNA GATTI Chief Operating Officer | Grant or award | +35,904 | 35,904 | ||
| 2020-09-17 | Beskrovnaya Oxana | Grant or award | +19,289 | 19,289 | ||
| 2020-09-17 | Subramanian Romesh Chief Scientific Officer | Grant or award | +41,309 | 566,249 | ||
| 2020-09-17 | McNeill Jonathan | Grant or award | +17,012 | 36,910 | ||
| 2020-09-17 | Brumm Joshua T | Grant or award | +107,027 | 107,027 | ||
| 2020-09-17 | Scalzo Richard William | Grant or award | +11,465 | 11,465 | ||
| 2020-09-16 | HIGH SUSANNA GATTI Chief Operating Officer | Grant or award · Stock Option (right to buy) | +111,405 | 111,405 | ||
| 2020-09-16 | Beskrovnaya Oxana | Grant or award · Stock Option (right to buy) | +59,857 | 59,857 | ||
| 2020-09-16 | Subramanian Romesh Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +128,185 | 128,185 | ||
| 2020-09-16 | McNeill Jonathan | Grant or award · Stock Option (right to buy) | +52,787 | 52,787 | ||
| 2020-09-16 | Brumm Joshua T | Grant or award · Stock Option (right to buy) | +320,781 | 320,781 |
Page 40 of 41 · 818 trades